Biotech Expert Brad Loncar Goes In-Depth on Coronavirus Treatments & Vaccines

Biotech expert Brad Loncar explains why COVID-19 should be taken seriously and goes in-depth on the companies rapidly developing treatments and vaccines.  ETF.com’s Drew Voros highlights ETF flows and discusses the Fed’s decision to purchase investment grade corporate bond ETFs.